Drugs.com - New Drug Approvals

FDA Approves Xifyrm (meloxicam) Injection for the Management of Moderate-to-Severe Pain in Adults

Woburn, MA — June 10, 2025 — Azurity Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Xifyrm (meloxicam injection) an IV non-steroidal anti-inflammatory drug (NSAID) that offers once...

Jun 11, 2025 - 00:20
 0
FDA Approves Xifyrm (meloxicam) Injection for the Management of Moderate-to-Severe Pain in Adults
Woburn, MA — June 10, 2025 — Azurity Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Xifyrm (meloxicam injection) an IV non-steroidal anti-inflammatory drug (NSAID) that offers once...
Read More

Tags:

Previous Article

Daimler And Toyota Plan Massive Merger Of Trucking Subsidiaries

Next Article

Pediatric Skin Care Regimens on TikTok Offer Few Benefits, Possible Harm

Related Posts

Celltrion's Yuflyma (adalimumab-aaty) Receives FDA Interchangeability Designation for All Approved Dosage Forms and Strengths

Celltrion's Yuflyma (adalimumab-aaty) Receives FDA Inte...

May 27, 2025  0

FDA Approves Enflonsia (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants

FDA Approves Enflonsia (clesrovimab-cfor) for Preventio...

Jun 9, 2025  0

FDA Approves Atzumi (dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine

FDA Approves Atzumi (dihydroergotamine) Nasal Powder fo...

May 12, 2025  0